# The Cancer of the Pancreas Screening-5 CAPS5)Study

> **NCT02000089** · PHASE3 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 9000 (estimated)

## Conditions studied

- Pancreas Cancer
- Peutz-Jeghers Syndrome (PJS)
- Gene Mutation
- Germline Mutation Carrier
- Lynch Syndrome

## Interventions

- **DRUG:** Secretin
- **DIAGNOSTIC_TEST:** MRI
- **OTHER:** Tumor marker gene test with CA19-9

## Key facts

- **NCT ID:** NCT02000089
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-01-06
- **Primary completion:** 2028-12
- **Final completion:** 2029-06
- **Target enrollment:** 9000 (ESTIMATED)
- **Last updated:** 2025-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02000089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02000089, "The Cancer of the Pancreas Screening-5 CAPS5)Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02000089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*